ScholarIQanswers from OpenAlex

Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness

PaperCitations, authors & open-access status

Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness have?

ScholarIQcitation count

Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness has 500 citations in the OpenAlex counts ScholarIQ stores.

When was Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness published?

ScholarIQyear

Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness has 2015 year in the ScholarIQ index.

What is the open-access status of Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness?

ScholarIQoa status

Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness has closed oa status in the ScholarIQ index.

What is the DOI of Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness?

ScholarIQdoi

The DOI for Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness is on the source record.

What is the PMID of Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness?

ScholarIQpmid

The PMID for Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness is on the source record.

What is the OpenAlex record for Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness?

ScholarIQopenalex

The OpenAlex for Safety and Benefit of Discontinuing Statin Therapy in the Setting of Advanced, Life-Limiting Illness is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial